Ajay K. Gopal
0000-0003-3023-6834
Publication & Citation Trends
Publications
613 total
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity PDF
Cited by 338
OpenAlex
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303
Cited by 417
OpenAlex
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017) PDF
Cited by 372
OpenAlex
Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma PDF
Cited by 391
OpenAlex
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma PDF
Cited by 1,058
OpenAlex
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma PDF
Cited by 1,505
OpenAlex
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Cited by 529
OpenAlex
Research Topics
Lymphoma Diagnosis and Treatment
(376)
CAR-T cell therapy research
(160)
Chronic Lymphocytic Leukemia Research
(142)
Monoclonal and Polyclonal Antibodies Research
(100)
Radiopharmaceutical Chemistry and Applications
(86)
Affiliations
Grady Memorial Hospital
Westchester Medical Center
Hackensack University Medical Center
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
Seattle Cancer Care Alliance